https://orcid.org/0000-0002-8530-8711
Citations (131)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Sandhya Karakkadparambil Sankaran & Achuthsankar S. Nair. (2023) Molecular dynamics and docking studies on potentially active natural phytochemicals for targeting SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics 41:14, pages 6459-6475.
Read now
Read now
Mohammed Baqur S. Al-Shuhaib, Sarfaraz Alam, Salman Ali Khan, Hayder O. Hashim, Daniel H. Obayes & Jafar M. B. Al-Shuhaib. (2023) Masoprocol: a promising candidate for targeting insulin resistance by inhibiting resistin with optimal druglikeness Potentials: an in silico approach. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Mohamed Moussaoui, Mouna Baassi, Soukayna Baammi, Hatim Soufi, Mohammed Salah, Rachid Daoud, Achraf EL Allali, M.E. Belghiti & Said Belaaouad. (2023) In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
Read now
Priyanka Purohit, Debashis Barik, Sidhartha Agasti, Madhusmita Panda & Biswa Ranjan Meher. (2023) Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now
Read now
Bibi Hanifa, Naila Bibi, Muhammad Sirajuddin, Edward R. T. Tiekink, Maciej Kubicki, Ishaq Khan, Ahmed Bari, Abdul Wadood & Sulaiman Shams. (2023) Synthesis, spectral characterisation, biocidal investigation, in-silico and molecular docking studies of 4-[(2-chloro-4-methylphenyl)carbamoyl]butanoic acid derived triorganotin(IV) compounds. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-20.
Read now
Read now
Mohammed Baqur S. Al-Shuhaib, Hayder O. Hashim, Jafar M. B. Al-Shuhaib & Daniel H. Obayes. (2023) Artecanin of Laurus nobilis is a novel inhibitor of SARS-CoV-2 main protease with highly desirable druglikeness. Journal of Biomolecular Structure and Dynamics 41:6, pages 2355-2367.
Read now
Read now
G. Mahaboob Basha, Rishikesh S. Parulekar, Abdullah G. Al-Sehemi, Mehboobali Pannipara, Vidavalur Siddaiah, Sunanda Kumari, Prafulla B. Choudhari & Yasinalli Tamboli. (2022) Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro. Journal of Biomolecular Structure and Dynamics 40:21, pages 11095-11110.
Read now
Read now
Soha R Abd El Hadi, Esmat E Zien El-Deen, Mostafa M Bahaa, Abdelfattah A Sadakah & Heba A Yassin. (2021) COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach. Drug Design, Development and Therapy 15, pages 3313-3330.
Read now
Read now
Alexander M. Andrianov, Yuri V. Kornoushenko, Anna D. Karpenko, Ivan P. Bosko & Alexander V. Tuzikov. (2021) Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics 39:15, pages 5779-5791.
Read now
Read now
Elham Tazikeh-Lemeski, Sajad Moradi, Rahim Raoufi, Mohsen Shahlaei, Mehr Ali Mahmood Janlou & Samaneh Zolghadri. (2021) Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. Journal of Biomolecular Structure and Dynamics 39:13, pages 4633-4646.
Read now
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 39:12, pages 4362-4374.
Read now
Read now
Mark Tristan J. Quimque, Kin Israel R. Notarte, Rey Arturo T. Fernandez, Mark Andrew O. Mendoza, Rhenz Alfred D. Liman, Justin Allen K. Lim, Luis Agustin E. Pilapil, Jehiel Karsten H. Ong, Adriel M. Pastrana, Abbas Khan, Dong-Qing Wei & Allan Patrick G. Macabeo. (2021) Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. Journal of Biomolecular Structure and Dynamics 39:12, pages 4316-4333.
Read now
Read now
Brandon Havranek & Shahidul M. Islam. (2021) An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease. Journal of Biomolecular Structure and Dynamics 39:12, pages 4304-4315.
Read now
Read now
Muhammad Amin & Ghazanfar Abbas. (2021) Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein – an in silico insight into the comparative efficacy of repurposing antiviral drugs. Journal of Biomolecular Structure and Dynamics 39:12, pages 4243-4255.
Read now
Read now
Anshuman Chandra, Vaishali Gurjar, Imteyaz Qamar & Nagendra Singh. (2021) Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure and Dynamics 39:12, pages 4201-4211.
Read now
Read now
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, Aaja Alosious, Mariya Luvis & Madhavan Nampoothiri. (2021) JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy. Postgraduate Medicine 133:5, pages 489-507.
Read now
Read now
Satyajit Beura & Prabhakar Chetti. (2021) In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 39:10, pages 3747-3759.
Read now
Read now
Naún Lobo-Galo, Manuel Terrazas-López, Alejandro Martínez-Martínez & Ángel Gabriel Díaz-Sánchez. (2021) FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics 39:9, pages 3419-3427.
Read now
Read now
Sourav Das, Sharat Sarmah, Sona Lyndem & Atanu Singha Roy. (2021) An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics 39:9, pages 3347-3357.
Read now
Read now
Imane Abdelli, Faiçal Hassani, Sohayb Bekkel Brikci & Said Ghalem. (2021) In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics 39:9, pages 3263-3276.
Read now
Read now
Saurabh K. Sinha, Anshul Shakya, Satyendra K. Prasad, Shashikant Singh, Nilambari S. Gurav, Rupali S. Prasad & Shailendra S. Gurav. (2021) An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets. Journal of Biomolecular Structure and Dynamics 39:9, pages 3244-3255.
Read now
Read now
Articles from other publishers (110)
Jawher Makhlouf, Youness El Bakri, Arto Valkonen, Kandasamy Saravanan, Sajjad Ahmad, Rashad Al-Salahi & Wajda Smirani. (2024) Self-assembly, virtual screening of a new cobalt complex: Synthesis, empirical, DFT calculations, biological activity investigations and identification of inhibitory activity on the main protease of COVID-19 and SARS-CoV2 by molecular docking strategy of (C6H6NF)2[Co(SCN)2]. Inorganic Chemistry Communications 159, pages 111723.
Crossref
Crossref
Kushagra NagoriMadhulika PradhanKartik T. NakhateHemant R. BadwaikReena DeshmukhAyushmaan RoyRashnita SharmaShobhit P. SrivastavaSonia ChawlaVishal JainMukesh Sharma. (2023) In silico Molecular Docking Analysis of some Terpenoids against 3CLpro of SARS-CoV-2. Research Journal of Pharmacy and Technology, pages 4791-4798.
Crossref
Crossref
Mariana Pereira & Nuno Vale. (2023) A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine. International Journal of Translational Medicine 3:4, pages 461-478.
Crossref
Crossref
Oumaima Kouira, Sonia Bayoudh, Houda Smati, Mohamed Bouzid, Fatma Aouaini & Abdelmottaleb Ben Lamine. (2023) Physicochemical modeling and characterization of the adsorption mechanism of seven pharmaceutical molecules onto SARS-CoV-2 virus. Materials Chemistry and Physics 307, pages 128219.
Crossref
Crossref
Shunan Kaping, Hakani Daioo Sympli, Labet Bankynmaw Marpna, Anitha Kandasamy & Jai N. Vishwakarma. (2023) Ultrasound assisted regioselective synthesis of novel adamantyl-pyrazolo[1,5-a]pyrimidines in aqueous media and molecular docking and drug likeness studies. Journal of Molecular Structure 1288, pages 135766.
Crossref
Crossref
Mohammad Rahimi, Majid Taghdir & Farzane Abasi Joozdani. (2023) Dynamozones are the most obvious sign of the evolution of conformational dynamics in HIV-1 protease. Scientific Reports 13:1.
Crossref
Crossref
Sophakama Zabo & Kevin Alan Lobb. (2023) In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (Mpro) Using Hexapeptide Substrates. Viruses 15:7, pages 1480.
Crossref
Crossref
Prejwal Prabhakaran, Ananda Vardhan Hebbani, Soumya V. Menon, Biswaranjan Paital, Sneha Murmu, Sunil Kumar, Mahender Kumar Singh, Dipak Kumar Sahoo & Padma Priya Dharmavaram Desai. (2023) Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CLpro) using deep learning. Frontiers in Microbiology 14.
Crossref
Crossref
Muhammed Muhsin Varikkodan, Faisal Kunnathodi, Sarfuddin Azmi & Tzong-Yuan Wu. (2023) An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need. Vaccines 11:6, pages 1102.
Crossref
Crossref
Luigi Genovese, William Dawson, Takahito Nakajima, Viviana Cristiglio, Valérie Vallet & Michel Masella. (2023)
Protein–ligand interactions from a quantum fragmentation perspective: The case of the SARS-CoV-2 main protease interacting with
α
-ketoamide inhibitors
. The Journal of Chemical Physics 158:21.
Crossref
Crossref
Kavitha KSrinivasan NSuresh RMohan S. (2023) In Silico Identification of Potential Inhibitors of Substituted Quinazolin-4-One against Main Protease and Spike Glycoprotein of Sars Cov-2. Research Journal of Pharmacy and Technology, pages 2470-2476.
Crossref
Crossref
Mazen Almehmadi, Ihtisham Ul Haq, Ahad Amer Alsaiari, Fahad M. Alshabrmi, Osama Abdulaziz, Mamdouh Allahyani, Mohammed Aladhadh, Alaa Shafie, Abdulelah Aljuaid, Rema Turki Alotaibi, Jawad Ullah & Nada Saud Alharthi. (2023) Identification of Small Molecule Inhibitors of Human Cytomegalovirus pUL89 Endonuclease Using Integrated Computational Approaches. Molecules 28:9, pages 3938.
Crossref
Crossref
Abdul Mateen Khan, Atia-tul-Wahab, Saba Farooq, Asmat Ullah & M. Iqbal Choudhary. (2023) Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays. International Journal of Biological Macromolecules 234, pages 123540.
Crossref
Crossref
Shabina Ishtiaq Ahmed, Sehrish Jamil, Humaira Ismatullah, Rashid Hussain, Shabana Bibi, Mayeen Uddin Khandaker, Aisha Naveed, Abubakr M. Idris & Talha Bin Emran. (2023) A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19. Saudi Journal of Biological Sciences 30:3, pages 103561.
Crossref
Crossref
Raghav Mishra, Kajal Chaudhary & Isha Mishra. (2023) Weapons and Strategies against COVID-19: A Perspective. Current Pharmaceutical Biotechnology 25:2, pages 144-158.
Crossref
Crossref
Xiaolong Gong, Amber Khan, Mohmmad Younus Wani, Aijaz Ahmad & Adriano Duse. (2023) COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte. Journal of Infection and Public Health 16:2, pages 233-249.
Crossref
Crossref
Zhiqiang Zhang. (2023) Computer Simulation Method for Data Trust Analysis Based on Average Deviation Algorithm. IEEE Access 11, pages 19602-19612.
Crossref
Crossref
André M. Oliveira & Mithun Rudrapal. 2023. CADD and Informatics in Drug Discovery. CADD and Informatics in Drug Discovery
175
204
.
Farai Mlambo, Cyril Chironda, Jaya George & David Mhlanga. 2023. The Fourth Industrial Revolution in Africa. The Fourth Industrial Revolution in Africa
117
149
.
Ling Ma, Yongli Xie, Mei Zhu, Dongrong Yi, Jianyuan Zhao, Saisai Guo, Yongxin Zhang, Jing Wang, Quanjie Li, Yucheng Wang & Shan Cen. (2022) Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro. International Journal of Molecular Sciences 23:24, pages 16011.
Crossref
Crossref
Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Van V. Vu, Minh Quan Pham & Binh Khanh Mai. (2022)
Characterizing the ligand-binding affinity toward SARS-CoV-2 Mpro
via
physics- and knowledge-based approaches
. Physical Chemistry Chemical Physics 24:48, pages 29266-29278.
Crossref
Crossref
Wamankar Suchita, Sahu Tilotma, Shrivastava Saurabh, Kumar Abhishek, Sahu Sagar & Kumar Lokesh. (2022) Molecular Elucidation and Therapeutic Targeting for Combating
COVID-19: Current Scenario and Future Prospective. Current Molecular Medicine 22:10, pages 894-907.
Crossref
Crossref
Konstantinos F. Kantelis, Vassilios Asteriou, Aliki Papadimitriou-Tsantarliotou, Anthi Petrou, Lefteris Angelis, Petros Nicopolitidis, Georgios Papadimitriou & Ioannis S. Vizirianakis. (2022) Graph theory-based simulation tools for protein structure networks. Simulation Modelling Practice and Theory 121, pages 102640.
Crossref
Crossref
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, Masoomeh Nazarabi, Yousef Fatahi, Omid Akhavan, Mohammad Rabiee, Ebrahim Mostafavi, Eder C. Lima, Mohammad Reza Saeb & Navid Rabiee. (2022)
A review on computer‐aided chemogenomics and drug repositioning for rational
COVID
‐19 drug discovery
. Chemical Biology & Drug Design 100:5, pages 699-721.
Crossref
Crossref
Jacob Andrzejczyk, Katarina Jovic, Logan M. Brown, Valerie G. Pascetta, Krisztina Varga & Harish Vashisth. (2022) Molecular interactions and inhibition of the SARS‐CoV‐2 main protease by a thiadiazolidinone derivative. Proteins: Structure, Function, and Bioinformatics 90:11, pages 1896-1907.
Crossref
Crossref
Alibek Kruglikov, Yulong Wei & Xuhua Xia. (2022)
Proteins from Thermophilic
Thermus thermophilus
Often Do Not Fold Correctly in a Mesophilic Expression System Such as
Escherichia coli
. ACS Omega 7:42, pages 37797-37806.
Crossref
Crossref
Ava Amidei & Hana M. Dobrovolny. (2022) Estimation of virus-mediated cell fusion rate of SARS-CoV-2. Virology 575, pages 91-100.
Crossref
Crossref
Hira Noor Malik, Almas Jabeen, Sajda Ashraf, Zaheer Ul Haq, Uzma Salar, Arshia & Khalid Mohammed Khan. (2022) Benzophenone and coumarin derivatives as 3-CLPro inhibitors: Targeting cytokine storm through in silico and in vitro approaches. Journal of Molecular Structure 1265, pages 133478.
Crossref
Crossref
Ossama Daoui, Souad Elkhattabi & Samir Chtita. (2022) Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CLpro enzyme for COVID-19 therapy: a computer-aided drug design approach. Structural Chemistry 33:5, pages 1667-1690.
Crossref
Crossref
Priyanka Andola, Jishu Pagag, Durgam Laxman & Lalitha Guruprasad. (2022) Fragment-based inhibitor design for SARS-CoV2 main protease. Structural Chemistry 33:5, pages 1467-1487.
Crossref
Crossref
Salman Ali Khan, Alamgir Khan, Komal Zia, Ihab Shawish, Assem Barakat & Zaheer Ul-Haq. (2022) Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein. International Journal of Molecular Sciences 23:18, pages 10315.
Crossref
Crossref
Alexey Sulimov, Ivan Ilin, Danil Kutov, Khidmet Shikhaliev, Dmitriy Shcherbakov, Oleg Pyankov, Nadezhda Stolpovskaya, Svetlana Medvedeva & Vladimir Sulimov. (2022) New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture. Molecules 27:17, pages 5732.
Crossref
Crossref
Wassila Derafa, Djouhra Aggoun, Zakia Messasma, Selma Houchi, Sofiane Bouacida & Ali Ourari. (2022) An unexpected single crystal structure of nickel(II) complex: Spectral, DFT, NLO, magnetic and molecular docking studies. Journal of Molecular Structure 1264, pages 133190.
Crossref
Crossref
Selma Houchi & Zakia Messasma. (2022) Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies. Journal of Molecular Structure 1263, pages 133032.
Crossref
Crossref
Paul Andrei Negru, Denisa Claudia Miculas, Tapan Behl, Alexa Florina Bungau, Ruxandra-Cristina Marin & Simona Gabriela Bungau. (2022) Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses. Biomedicine & Pharmacotherapy 153, pages 113432.
Crossref
Crossref
Yasmin Akter, Rocktim Barua, Md. Nasir Uddin, Abul Fazal Muhammad Sanaullah & Lolo Wal Marzan. (2022) Bioactive potentiality of secondary metabolites from endophytic bacteria against SARS-COV-2: An in-silico approach. PLOS ONE 17:8, pages e0269962.
Crossref
Crossref
Mohammad Faheem Khan, Waseem Ahmad Ansari, Tanveer Ahamad, Mohsin Ali Khan, Zaw Ali Khan, Aqib Sarfraz & Mohd Aamish Khan. (2022) Bioactive components of different nasal spray solutions may defeat SARS-Cov2: repurposing and in silico studies. Journal of Molecular Modeling 28:8.
Crossref
Crossref
Panagiotis Zagaliotis, Anthi Petrou, George Mystridis, Athina Geronikaki, Ioannis Vizirianakis & Thomas Walsh. (2022) Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences 23:14, pages 8006.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Garima Singh, Abhay Tiwari, Gourav Choudhir, Anuj Kumar, Sushil Kumar, P. Hariprasad & Satyawati Sharma. (2022) Deciphering the role of Trichoderma sp. bioactives in combating the wilt causing cell wall degrading enzyme polygalacturonase produced by Fusarium oxysporum: An in-silico approach. Microbial Pathogenesis 168, pages 105610.
Crossref
Crossref
Mohd Yousuf, Anas Shamsi, Shama Khan, Parvez Khan, Moyad Shahwan, Abdelbaset Mohamed Elasbali, Qazi Mohd Rizwanul Haque & Md. Imtaiyaz Hassan. (2022) Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics. International Journal of Biological Macromolecules 213, pages 944-954.
Crossref
Crossref
Shama Khan, Fahad A. Alhumaydhi, Mohd Shahnawaz Khan, Sharaf E. Sharaf, Waleed Al Abdulmonem, Md. Imtaiyaz Hassan, Anas Shamsi & Dharmendra Kumar Yadav. (2022) Exploring binding mechanism of naringenin to human transferrin using combined spectroscopic and computational methods: Towards therapeutic targeting of neurodegenerative diseases. Journal of Molecular Liquids 356, pages 119001.
Crossref
Crossref
Lukas Bucinsky, Dušan Bortňák, Marián Gall, Ján Matúška, Viktor Milata, Michal Pitoňák, Marek Štekláč, Daniel Végh & Dávid Zajaček. (2022) Machine learning prediction of 3CL SARS-CoV-2 docking scores. Computational Biology and Chemistry 98, pages 107656.
Crossref
Crossref
Mohamed Fadlalla, Mazin Ahmed, Musab Ali, Abdulrhman A. Elshiekh & Bashir A. Yousef. (2022) Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models. Current Pharmacology Reports 8:3, pages 212-226.
Crossref
Crossref
Vajiheh Eskandari. (2022) Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein. Journal of Molecular Modeling 28:6.
Crossref
Crossref
Anuj Kumar, Mansi Sharma, Christopher D. Richardson & David J. Kelvin. (2022) Potential of Natural Alkaloids From Jadwar (Delphinium denudatum) as Inhibitors Against Main Protease of COVID-19: A Molecular Modeling Approach. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Eman Zeyad I. Elmekaty, Rim Alibrahim, Rania Hassanin, Sitelbanat Eltaib, Ahmed Elsayed, Fatima Rustom, Mohamed Izham Mohamed Ibrahim, Mohammed Abu Khattab, Hussam Al Soub, Muna Al Maslamani & Abdullatif Al-Khal. (2022) Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study. PLOS ONE 17:5, pages e0267884.
Crossref
Crossref
Sourav Das, Anirudh Singh, Sintu Kumar Samanta & Atanu Singha Roy. (2022) Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study. Biologia 77:4, pages 1121-1134.
Crossref
Crossref
Felix I. L. Clanchy, Yi-Shu Huang, Joy Ogbechi, L. Gail Darlington, Richard O. Williams & Trevor W. Stone. (2022) Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?. Frontiers in Immunology 13.
Crossref
Crossref
Nasim Shahhamzehei, Sara Abdelfatah & Thomas Efferth. (2022) In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library. Pharmaceuticals 15:3, pages 308.
Crossref
Crossref
Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea, Corina Duda Seiman, Daniel Duda Seiman & Carmen Chifiriuc. (2022) Structural Bioinformatics Used to Predict the Protein Targets of
Remdesivir and Flavones in SARS-CoV-2 Infection. Medicinal Chemistry 18:3, pages 382-393.
Crossref
Crossref
Nilanjan Adhikari, Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh & Tarun Jha. (2022) Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences. Journal of Molecular Structure 1251, pages 132041.
Crossref
Crossref
Smitha Sammith ShettyVignesh KamathShibani ShettySwapna Bettanapalya VenkateshShrivardhan Kalghatgi. (2022) An Overview on Treatment Strategies by Allopathic and Alternative Forms of Medicines in Management of COVID -19. Research Journal of Pharmacy and Technology, pages 935-940.
Crossref
Crossref
Abdulrahim R Hakami, Ahmed H Bakheit, Abdulrahman A Almehizia & Mohammed Y Ghazwani. (2022) Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening. Future Medicinal Chemistry 14:2, pages 61-79.
Crossref
Crossref
Abdelkrim Benalia, Hasnia Abdeldjebar & Taqiy Eddine Badji. (2022) Computational Docking Study of Calanolides as Potential Inhibitors of SARS-CoV-2 Main Protease. French-Ukrainian Journal of Chemistry 10:1, pages 48-59.
Crossref
Crossref
Elia Grueso, Rosa M. Giráldez-Pérez & Rafael Prado-Gotor. 2022. Advanced Nanomaterials. Advanced Nanomaterials
445
495
.
Rajeev K. Singla, Xuefei He, Hitesh Chopra, Christos Tsagkaris, Li Shen, Mohammad Amjad Kamal & Bairong Shen. (2021) Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources. Frontiers in Pharmacology 12.
Crossref
Crossref
Illya Aronskyy, Yosef Masoudi-Sobhanzadeh, Antonio Cappuccio & Elena Zaslavsky. (2021) Advances in the computational landscape for repurposed drugs against COVID-19. Drug Discovery Today 26:12, pages 2800-2815.
Crossref
Crossref
Inemesit A. Udofia, Kofoworola O. Gbayo, Oluwakemi A. Oloba-Whenu, Taofeek B. Ogunbayo & Chukwuemeka Isanbor. (2021) In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV. Network Modeling Analysis in Health Informatics and Bioinformatics 10:1.
Crossref
Crossref
Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar & Brijesh Rathi. (2021) Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. RSC Advances 11:57, pages 36181-36198.
Crossref
Crossref
Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai & Dinesh Kumar. (2021) Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study. Frontiers in Chemistry 9.
Crossref
Crossref
Shafi Mahmud, Md. Robiul Hasan, Suvro Biswas, Gobindo Kumar Paul, Shamima Afrose, Mohsana Akter Mita, Mst. Sharmin Sultana Shimu, Maria Meha Promi, Umme Hani, Mohamed Rahamathulla, Md. Arif Khan, Shahriar Zaman, Md. Salah Uddin, Mohammed Rahmatullah, Rownak Jahan, Ali M. Alqahtani, Md. Abu Saleh & Talha Bin Emran. (2021) Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach. Frontiers in Bioinformatics 1.
Crossref
Crossref
Chun‐Chi Chen, Xuejing Yu, Chih‐Jung Kuo, Jian Min, Sizhuo Chen, Lixin Ma, Ke Liu & Rey‐Ting Guo. (2021) Overview of antiviral drug candidates targeting coronaviral 3C‐like main proteases. The FEBS Journal 288:17, pages 5089-5121.
Crossref
Crossref
Hai Trong Nguyen, Darryl Falzarano, Volker Gerdts & Qiang Liu. (2021) Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Journal of Virology 95:18.
Crossref
Crossref
Devashan Naidoo, Pallab Kar, Ayan Roy, Taurai Mutanda, Joseph Bwapwa, Arnab Sen & Akash Anandraj. (2021) Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations. Molecules 26:17, pages 5114.
Crossref
Crossref
Aditya K. Padhi, Soumya Lipsa Rath & Timir Tripathi. (2021) Accelerating COVID-19 Research Using Molecular Dynamics Simulation. The Journal of Physical Chemistry B 125:32, pages 9078-9091.
Crossref
Crossref
Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Olorunfemi R. Molehin & Courage D. Famusiwa. (2021) Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation. In Silico Pharmacology 9:1.
Crossref
Crossref
Bhaskarjyoti Gogoi, Purvita Chowdhury, Nabajyoti Goswami, Neelutpal Gogoi, Tufan Naiya, Pankaj Chetia, Saurov Mahanta, Dipak Chetia, Bhaben Tanti, Probodh Borah & Pratap Jyoti Handique. (2021) Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Molecular Diversity 25:3, pages 1963-1977.
Crossref
Crossref
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Francesco Cimino, Antonella Saija & Salvatore Vincenzo Giofrè. (2021)
Silibinin as potential tool against
SARS‐Cov
‐2: In silico spike
receptor‐binding
domain and main protease molecular docking analysis, and in vitro endothelial protective effects
. Phytotherapy Research 35:8, pages 4616-4625.
Crossref
Crossref
Majid Hassanzadeganroudsari, Amir Ahmadi, Niloufar Rashidi, Md Hossain, Amanda Habib & Vasso Apostolopoulos. (2021) Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 1:2, pages 111-128.
Crossref
Crossref
José Rogério A. Silva, Hendrik G. Kruger & Fábio A. Molfetta. (2021)
Drug repurposing and computational modeling for discovery of inhibitors of the main protease (M
pro
) of SARS-CoV-2
. RSC Advances 11:38, pages 23450-23458.
Crossref
Crossref
Yuqing Chen, Xinping Xi, Chengbang Ma, Mei Zhou, Xiaoling Chen, Zhuming Ye, Lilin Ge, Qinan Wu, Tianbao Chen, Lei Wang & Hang Fai Kwok. (2021) Structure–Activity Relationship and Molecular Docking of a Kunitz-Like Trypsin Inhibitor, Kunitzin-AH, from the Skin Secretion of Amolops hainanensis. Pharmaceutics 13:7, pages 966.
Crossref
Crossref
Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, Mohasana Akter Mita, Maria Meha Promi, Shamima Afrose, Md. Robiul Hasan, Shahriar Zaman, Md. Salah Uddin, Kuldeep Dhama, Talha Bin Emran, Md. Abu Saleh & Jesus Simal-Gandara. (2021) Plant-Based Phytochemical Screening by Targeting Main Protease of SARS-CoV-2 to Design Effective Potent Inhibitors. Biology 10:7, pages 589.
Crossref
Crossref
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah & Khalid Mashay Al-Anazi. (2021) An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. BioMed Research International 2021, pages 1-18.
Crossref
Crossref
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Marialaura Bonaccio, Raffaele Bruno, Roberto Cauda, Alessandro Gialluisi, Giovanni Guaraldi, Lorenzo Menicanti, Marco Mennuni, Ilaria My, Agostino Parruti, Giuseppe Patti, Stefano Perlini, Francesca Santilli, Carlo Signorelli, Giulio G. Stefanini, Alessandra Vergori, Walter Ageno, Luca Aiello, Piergiuseppe Agostoni, Samir Al Moghazi, Rosa Arboretti, Filippo Aucella, Greta Barbieri, Martina Barchitta, Alessandro Bartoloni, Carolina Bologna, Paolo Bonfanti, Lucia Caiano, Laura Carrozzi, Antonio Cascio, Giacomo Castiglione, Mauro Chiarito, Arturo Ciccullo, Antonella Cingolani, Francesco Cipollone, Claudia Colomba, Crizia Colombo, Francesco Crosta, Giovanni Dalena, Chiara Dal Pra, Gian Battista Danzi, Damiano D'Ardes, Katleen de Gaetano Donati, Francesco Di Gennaro, Giuseppe Di Tano, Gianpiero D'Offizi, Tommaso Filippini, Francesco Maria Fusco, Carlo Gaudiosi, Ivan Gentile, Giancarlo Gini, Elvira Grandone, Gabriella Guarnieri, Gennaro L. F. Lamanna, Giovanni Larizza, Armando Leone, Veronica Lio, Angela Raffaella Losito, Gloria Maccagni, Stefano Maitan, Sandro Mancarella, Rosa Manuele, Massimo Mapelli, Riccardo Maragna, Lorenzo Marra, Giulio Maresca, Claudia Marotta, Franco Mastroianni, Maria Mazzitelli, Alessandro Mengozzi, Francesco Menichetti, Jovana Milic, Filippo Minutolo, Beatrice Molena, R. Mussinelli, Cristina Mussini, Maria Musso, Anna Odone, Marco Olivieri, Emanuela Pasi, Annalisa Perroni, Francesco Petri, Biagio Pinchera, Carlo A. Pivato, Venerino Poletti, Claudia Ravaglia, Marco Rossato, Marianna Rossi, Anna Sabena, Francesco Salinaro, Vincenzo Sangiovanni, Carlo Sanrocco, Laura Scorzolini, Raffaella Sgariglia, Paola Giustina Simeone, Michele Spinicci, Enrico Maria Trecarichi, Giovanni Veronesi, Roberto Vettor, Andrea Vianello, Marco Vinceti, Elena Visconti, Laura Vocciante, Raffaele De Caterina & Licia Iacoviello. (2021) Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study. Frontiers in Medicine 8.
Crossref
Crossref
Ruichao Mao, Lihua Bie, Maofeng Xu, Xiaocong Wang & Jun Gao. (2021) Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2. Physical Chemistry Chemical Physics 23:22, pages 12549-12558.
Crossref
Crossref
Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Khaled S. Allemailem, Ahmad Almatroudi, Mahmoud F. Moustafa & Mohamed-Elamir F. Hegazy. (2021) In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. The Protein Journal 40:3, pages 296-309.
Crossref
Crossref
Mycal Dutta, Mohammad Nezam, Subrata Chowdhury, Ahmed Rakib, Arkajyoti Paul, Saad Ahmed Sami, Md. Zia Uddin, Md. Sohel Rana, Shahadat Hossain, Yunus Effendi, Rinaldi Idroes, Trina Tallei, Ali M. Alqahtani & Talha Bin Emran. (2021) Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Luana Bauso, Chiara Imbesi, Gasparo Irene, Gabriella Calì & Alessandra Bitto. (2021) New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection. Pharmaceuticals 14:6, pages 503.
Crossref
Crossref
Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim & Md. Sahab Uddin. (2021) Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Frontiers in Pharmacology 12.
Crossref
Crossref
Leif E. Peterson. (2021) In Silico Molecular Dynamics Docking of Drugs to the Inhibitory Active Site of SARS-CoV-2 Protease and Their Predicted Toxicology and ADME. African Journal of Pharmaceutical Sciences 1:2, pages 16.
Crossref
Crossref
Rajveer Singh, Anupam Gautam, Shivani Chandel, Vipul Sharma, Arijit Ghosh, Dhritiman Dey, Syamal Roy, V. Ravichandiran & Dipanjan Ghosh. (2021) Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: a multiple target approach. In Silico Pharmacology 9:1.
Crossref
Crossref
Saba Farooq & Zainab Ngaini. (2020) Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019). Chemistry Africa 4:1, pages 1-13.
Crossref
Crossref
U. Rutwick Surya & N. Praveen. (2021) A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. VirusDisease 32:1, pages 46-54.
Crossref
Crossref
Shashanka K. Prasad, Sushma Pradeep, Chandan Shimavallu, Shiva Prasad Kollur, Asad Syed, Najat Marraiki, Chukwuebuka Egbuna, Mihnea-Alexandru Gaman, Olga Kosakowska, William C. Cho, Kingsley Chukwuemeka Patrick-Iwuanyanwu, Joaquín Ortega Castro, Juan Frau, Norma Flores-Holguín & Daniel Glossman-Mitnik. (2021) Evaluation of Annona muricata Acetogenins as Potential Anti-SARS-CoV-2 Agents Through Computational Approaches. Frontiers in Chemistry 8.
Crossref
Crossref
Konstantina Vougogiannopoulou, Angela Corona, Enzo Tramontano, Michael N. Alexis & Alexios-Leandros Skaltsounis. (2021) Natural and Nature-Derived Products Targeting Human Coronaviruses. Molecules 26:2, pages 448.
Crossref
Crossref
Gihanna Galindez, Julian Matschinske, Tim Daniel Rose, Sepideh Sadegh, Marisol Salgado-Albarrán, Julian Späth, Jan Baumbach & Josch Konstantin Pauling. (2021) Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies. Nature Computational Science 1:1, pages 33-41.
Crossref
Crossref
David Livingstone Alves Figueiredo, João Paulo Bianchi Ximenez, Fábio Rodrigues Ferreira Seiva, Carolina Panis, Rafael dos Santos Bezerra, Adriano Ferrasa, Alessandra Lourenço Cecchini, Alexandra Ivo de Medeiros, Ana Marisa Fusco Almeida, Anelisa Ramão, Angelica Beate Winter Boldt, Carla Fredrichsen Moya, Chung Man Chin, Daniel de Paula, Daniel Rech, Daniela Fiori Gradia, Danielle Malheiros, Danielle Venturini, Eliandro Reis Tavares, Emerson Carraro, Enilze Maria de Souza Fonseca Ribeiro, Evani Marques Pereira, Felipe Francisco Tuon, Franciele Aní Caovilla Follador, Glaura Scantamburlo Alves Fernandes, Hélito Volpato, Ilce Mara de Syllos Cólus, Jaqueline Carvalho de Oliveira, Jean Henrique da Silva Rodrigues, Jean Leandro dos Santos, Jeane Eliete Laguila Visentainer, Juliana Cristina Brandi, Juliana Mara Serpeloni, Juliana Sartori Bonini, Karen Brajão de Oliveira, Karine Fiorentin, Léia Carolina Lucio, Ligia Carla Faccin-Galhardi, Lirane Elize Defante Ferreto, Lucy Megumi Yamauchi Lioni, Marcia Edilaine Lopes Consolaro, Marcelo Ricardo Vicari, Marcos Abdo Arbex, Marcos Pileggi, Maria Angelica Ehara Watanabe, Maria Antônia Ramos Costa, Maria José S. Mendes Giannini, Marla Karine Amarante, Najeh Maissar Khalil, Quirino Alves de Lima Neto, Roberto H. Herai, Roberta Losi Guembarovski, Rogério N. Shinsato, Rubiana Mara Mainardes, Silvana Giuliatti, Sueli Fumie Yamada-Ogatta, Viviane Knuppel de Quadros Gerber, Wander Rogério Pavanelli, Weber Claudio da Silva, Maria Luiza Petzl-Erler, Valeria Valente, Christiane Pienna Soares, Luciane Regina Cavalli & Wilson Araujo Silva Jr. (2021) COVID-19: The question of genetic diversity and therapeutic intervention approaches. Genetics and Molecular Biology 44:1 suppl 1.
Crossref
Crossref
Nahid Shahabadi, Saba Zendehcheshm, Mohammad Mahdavi & Fatemeh Khademi. (2021) Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach. Informatics in Medicine Unlocked 26, pages 100745.
Crossref
Crossref
Anna Tashchilova, Alexey Sulimov, Ivan Ilin, Danil Kutov & Vladimir Sulimov. 2021. Supercomputing. Supercomputing
17
28
.
Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, Kiran Kalia & Rakesh Kumar Tekade. (2020) Current Scenario and Future Prospect in the Management of COVID-19. Current Medicinal Chemistry 28:2, pages 284-307.
Crossref
Crossref
Thakur Uttam Singh, Subhashree Parida, Madhu Cholenahalli Lingaraju, Manickam Kesavan, Dinesh Kumar & Raj Kumar Singh. (2020) Drug repurposing approach to fight COVID-19. Pharmacological Reports 72:6, pages 1479-1508.
Crossref
Crossref
Phongthon Kanjanasirirat, Ampa Suksatu, Suwimon Manopwisedjaroen, Bamroong Munyoo, Patoomratana Tuchinda, Kedchin Jearawuttanakul, Sawinee Seemakhan, Sitthivut Charoensutthivarakul, Patompon Wongtrakoongate, Noppawan Rangkasenee, Supaporn Pitiporn, Neti Waranuch, Napason Chabang, Phisit Khemawoot, Khanit Sa-ngiamsuntorn, Yongyut Pewkliang, Piyanoot Thongsri, Somchai Chutipongtanate, Suradej Hongeng, Suparerk Borwornpinyo & Arunee Thitithanyanont. (2020) High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents. Scientific Reports 10:1.
Crossref
Crossref
Eduardo Tejera, Cristian R. Munteanu, Andrés López-Cortés, Alejandro Cabrera-Andrade & Yunierkis Pérez-Castillo. (2020) Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease. Molecules 25:21, pages 5172.
Crossref
Crossref
Antonio Francés-Monerris, Cécilia Hognon, Tom Miclot, Cristina García-Iriepa, Isabel Iriepa, Alessio Terenzi, Stéphanie Grandemange, Giampaolo Barone, Marco Marazzi & Antonio Monari. (2020) Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation Approaches. Journal of Proteome Research 19:11, pages 4291-4315.
Crossref
Crossref
Anna-Gaelle Giguet-Valard, Kevin Raguette, Stephanie Morin, Remi Bellance & Juliette Smith Ravin. (2020) Gossypetin Derivatives are also Putative Inhibitors of SARS-COV 2: Results of a Computational Study. Journal of Biomedical Research & Environmental Sciences 1:6, pages 201-212.
Crossref
Crossref
Sairaj Satarker, Tejas Ahuja, Madhuparna Banerjee, Vignesh Balaji E, Shagun Dogra, Tushar Agarwal & Madhavan Nampoothiri. (2020) Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2. Current Pharmacology Reports 6:5, pages 203-211.
Crossref
Crossref
Giulia Culletta, Maria Rita Gulotta, Ugo Perricone, Maria Zappalà, Anna Maria Almerico & Marco Tutone. (2020) Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach. Computation 8:3, pages 77.
Crossref
Crossref
Siddhi Joshi, Maithili Joshi & Mariam S Degani. (2020) Tackling SARS-CoV-2: proposed targets and repurposed drugs. Future Medicinal Chemistry 12:17, pages 1579-1601.
Crossref
Crossref
Chunsheng Zhu, Bao Sun, Xiaochuan Zhang & Bing Zhang. (2020) Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019. Frontiers in Pharmacology 11.
Crossref
Crossref
Lyndsey Elaine Gates & Ahmed Abdeen Hamed. (2020) The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation. Journal of Medical Internet Research 22:8, pages e21169.
Crossref
Crossref
Farhana Rumzum Bhuiyan, Sabbir Howlader, Topu Raihan & Mahmudul Hasan. (2020) Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic. Frontiers in Medicine 7.
Crossref
Crossref
Ellen WeisbergMartin SattlerPriscilla L. YangAlexander ParentNathanael GrayJames D. Griffin. (2020) Current therapies under investigation for COVID-19: potential COVID-19 treatments. Canadian Journal of Physiology and Pharmacology 98:8, pages 483-489.
Crossref
Crossref
Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk & Hans-Peter Deigner. (2020) COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences 21:14, pages 4953.
Crossref
Crossref
Joseph T. Ortega, Maria Luisa Serrano & Beata Jastrzebska. (2020) Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative against SARS-CoV2: An In Silico Analysis. Biomolecules 10:6, pages 954.
Crossref
Crossref
Naser F. Al-Tannak, Ladislav Novotny & Adel Alhunayan. (2020) Remdesivir—Bringing Hope for COVID-19 Treatment. Scientia Pharmaceutica 88:2, pages 29.
Crossref
Crossref
Phaedra Eleftheriou, Dionysia Amanatidou, Anthi Petrou & Athina Geronikaki. (2020) In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Molecules 25:11, pages 2529.
Crossref
Crossref
Jiansheng Huang, Wenliang Song, Hui Huang & Quancai Sun. (2020) Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19. Journal of Clinical Medicine 9:4, pages 1131.
Crossref
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
329
431
.
Dharshini Gopal & Sinosh Skariyachan. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
433
471
.